AI Article Synopsis
Article Abstract
Aims: This study aimed to test whether there are sex differences in the relationship between impulsivity and amphetamine use disorder (AMP).
Design: A naturalistic cross-sectional design was used.
Setting: The Tulsa 1000 study was held in Tulsa, OK, USA.
Participants: There were two groups in this study: AMP+ (29F, 20M) and AMP- (57F, 33M).
Measurements: This project focuses on data related to impulsivity: UPPS-P impulsive behavior scale and a stop signal task (SST) during functional magnetic resonance imaging (fMRI) recording. Group, sex and their interaction were compared for UPPS-P ratings and SST fMRI and behavioral responses.
Findings: AMP+ reported higher UPPS-P positive and negative urgency scores (Ps < 0.001; r = 0.56 and 0.51) and displayed greater bilateral insula and amygdala responses across correct SST trials (Ps < 0.001, g range = 0.57-0.81) than AMP-. fMRI results indicated that AMP+ exhibited larger right anterior/middle insula, amygdala and nucleus accumbens signals during successful difficult stop trials than AMP- (Ps < 0.01; g = 0.63, 0.54 and 0.44, respectively). Crucially, two group × sex effects emerged: (a) within females, AMP+ reported larger UPPS-P lack of premeditation scores than AMP- (P < 0.001, r = 0.51), and (b) within males, AMP+ showed greater left middle insula signals than AMP- across correct SST trials (P = 0.01, g = 0.78).
Conclusions: Both female and male amphetamine users appear to be characterized by rash action in the presence of positive and negative mood states as well as heightened recruitment of right hemisphere regions during behavioral inhibition. In contrast, planning ahead may be particularly difficult for female amphetamine users, whereas male amphetamine users may need to recruit additional left hemisphere resources during inhibitory processing.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524483 | PMC |
| http://dx.doi.org/10.1111/add.16225 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study.
Neuropsychopharmacology
December 2024
Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
3-Methylmethcathinone (3-MMC) is a designer drug that belongs to the group of synthetic cathinones. The compound has been scheduled in many jurisdictions because of public health concerns associated with excessive use. To date, there are no clinical studies that have evaluated the risk profile of 3-MMC in the recreational range of low to moderate doses.
View Article and Find Full Text PDFAssessment of impulsivity using an automated, self-adjusting delay discounting procedure.
Behav Brain Res
December 2024
Department of Anatomy and Neurosciences, Amsterdam Neuroscience, Amsterdam University Medical Center, location VU Medical Center, Amsterdam, The Netherlands. Electronic address:
Modelling delay discounting behavior in rodents is important for understanding the neurobiological mechanisms underlying cognitive control and associated impulsivity disorders. Conventional rodent delay discounting procedures require extensive training and frequent experimenter interaction, as rodents are tested in separate operant chambers away from their home cage. To address these limitations, we adapted and characterize here a self-adjusting delay discounting procedure to an automated CombiCage setup.
View Article and Find Full Text PDFGlutamate concentration of medial prefrontal cortex is inversely associated with addictive behaviors: a translational study.
Transl Psychiatry
October 2024
Department of Psychology and Behavioral Sciences, Zhejiang University, Hangzhou, 311100, China.
Article Synopsis
- Dysregulated frontostriatal circuits are linked to compulsive behaviors in substance use disorders and behavioral addictions, but the specific neurochemical causes are still unclear.
- A study combining rat models and human participants found that lower glutamate (Glu) levels in certain brain regions correlate with higher addictive behaviors and symptoms of internet gaming disorder (IGD).
- The findings suggest that increasing glutamatergic function in these brain regions could be a potential strategy for preventing and treating addiction.
Heat Stroke in a Young Athlete With Attention Deficit Hyperactivity Disorder on Stimulant Medication.
Cureus
August 2024
Internal Medicine, Howard University Hospital, Washington, DC, USA.
Article Synopsis
- ADHD is a neurodevelopmental disorder that leads to issues with attention, hyperactivity, and impulsivity, affecting daily life from childhood into adulthood.
- Heat stroke is a serious condition that can cause severe health problems, including seizures and high body temperature, and is especially dangerous for young athletes.
- The case discussed involves a young athlete with ADHD who experienced heat stroke, which may have been influenced by his ADHD medication, Adderall.
Psychedelics: From Cave Art to 21st-Century Medicine for Addiction.
Eur Addict Res
October 2024
Division of Brain Sciences, Centre for Psychiatry, Imperial College London, Commonwealth Building, Hammersmith Campus, London, UK.
Background: Psychedelic substance use in ritualistic and ceremonial settings dates back as early as 8,500 BCE. Only in recent years, from the mid-20th century, we have seen the re-emergence of psychedelics in a therapeutic setting and more specifically for the treatment of addiction. This article aims to review research over the past 40 years using classic (psilocybin, lysergic acid diethylamide [LSD], dimethyltryptamine [DMT], mescaline) and atypical (ketamine, ibogaine, 5-MeO-DMT, 3,4-methylenedioxymethamphetamine) psychedelics for the treatment of addiction.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!